Technically, NAD+ isn't a peptide — it's a coenzyme. But it belongs in the Peptide U by BritePear curriculum because it's foundational to understanding why your cells age and why metabolic health matters at the cellular level. It also intersects directly with GLP-1 biology and weight loss physiology in ways worth knowing.
What Is NAD+?
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It functions as an electron carrier in cellular respiration — the process by which your mitochondria convert nutrients into ATP (usable energy). Without adequate NAD+, your mitochondria can't function efficiently, meaning less energy production from the food you eat.[1]
But NAD+ does more than energy metabolism. It's also a required substrate for sirtuins — a family of proteins sometimes called "longevity genes." Sirtuins regulate inflammation, DNA repair, and metabolic efficiency. They need NAD+ to function. No NAD+, no sirtuin activity.[2]
The Decline Problem
Here's the problem: NAD+ levels drop significantly with age. By middle age, most people have roughly half the NAD+ of a young adult. Obesity, metabolic syndrome, and chronic inflammation accelerate this decline further.[3] This creates a vicious cycle — lower NAD+ means less efficient energy metabolism and less sirtuin activity, which contributes to more metabolic dysfunction, which further depletes NAD+.
For someone who has carried significant weight for years and is now actively losing it, understanding this cellular energy context is directly relevant — not abstract biology.
"David Sinclair at Harvard has called NAD+ decline 'a key driver of aging' and has published extensively on NAD+ restoration as a longevity strategy. His work has moved this from fringe to mainstream research conversation in under a decade."
NMN and NR: The Precursors
You can't effectively supplement NAD+ directly — it's a large molecule that doesn't readily enter cells intact. Instead, research has focused on precursor molecules that the body converts to NAD+.
NMN (Nicotinamide Mononucleotide)
NMN has been at the center of most longevity-focused research. Animal studies — including several from Sinclair's lab — showed dramatic improvements in energy metabolism, insulin sensitivity, muscle function, and even reversal of some aging markers in old mice given NMN supplementation.[4]
Human clinical trials have now confirmed that oral NMN supplementation raises blood NAD+ levels in a dose-dependent manner with a favorable safety profile.[5] A 2021 randomized controlled trial in Japan showed that 250mg/day NMN over 12 weeks significantly increased NAD+ in older men and improved muscle function metrics.[6]
NR (Nicotinamide Riboside)
NR is further along in human trial data. Multiple randomized trials have confirmed it raises NAD+ levels reliably, with favorable safety profiles. Studies in older adults have shown improvements in blood pressure, inflammation markers, and insulin sensitivity.[7]
The GLP-1 Connection
This is underappreciated: GLP-1 medications and NAD+ metabolism intersect. Metabolic syndrome — the complex of obesity, insulin resistance, and inflammation — is associated with both NAD+ depletion and GLP-1 receptor pathway dysfunction. As GLP-1 medications improve metabolic function, the NAD+ system's capacity to support that recovery matters. Some researchers are now exploring combination approaches.[8]
Practical Takeaway
Of everything in Peptide U, NAD+ precursors are among the most accessible — available at supplement retailers, with growing clinical trial data, and with a straightforward mechanism that's well understood. The unknowns are around optimal dosing, which precursor is most effective long-term, and whether the benefits seen in animal models fully translate. But the safety profile is strong and the biology is compelling. This is a conversation you can have with almost any physician, not just one specialized in peptide medicine.